Functional Characterization of Reappearing B Cells After Anti-Cd20 Treatment of CNS Autoimmune Disease

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1810470115
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Autoreactive CD19+CD20−Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis

Journal of Immunology
AllergyImmunology
2016English

Role of B Cells in Rheumatic Autoimmune Disease

The Open Arthritis Journal,
2010English

IL-10-producing Regulatory B Cells (B10 Cells) in Autoimmune Disease

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2013English

AB0458 B Cells Depletion for the Treatment of Systemic Autoimmune Diseases

2017English

CNS Autoimmune Disease After Streptococcus Pyogenes Infections: Animal Models, Cellular Mechanisms and Genetic Factors

Future Neurology
Neurology
2016English

Human B Regulatory Cells: The New Players in Autoimmune Disease

Revista de Investigacion Clinica
Medicine
2017English

Treatment of Graves' Disease and Associated Ophthalmopathy With the Anti-Cd20 Monoclonal Antibody Rituximab: An Open Study

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2007English

The Mechanism of Anti-CD20–mediated B Cell Depletion Revealed by Intravital Imaging

Journal of Clinical Investigation
Medicine
2013English

B Cell Therapy for Rheumatoid Arthritis: The Rituximab (Anti-Cd20) Experience

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy